Squalamine

Squalamine is a steroid derived from the dogfish shark (Squalus acanthias). It was first isolated and identified in 1993 by Dr. Michael Zasloff and his team. Squalamine is a natural product that exhibits broad-spectrum antimicrobial and antiangiogenic properties.

Chemistry[edit]

Squalamine is a polyamine-steroid conjugate, consisting of a 7,24-dihydroxylated 24-sulfated cholic acid, linked to a spermidine at the C-3 position. The molecule is amphipathic, meaning it has both hydrophilic and hydrophobic properties, which allows it to interact with cell membranes.

Biological Activity[edit]

Squalamine has been found to exhibit a broad range of biological activities. It has potent antimicrobial activity against a variety of bacteria, fungi, and protozoa. It also exhibits potent antiangiogenic activity, which has led to its investigation as a potential treatment for cancer and age-related macular degeneration (AMD).

Antimicrobial Activity[edit]

Squalamine interacts with the cell membrane of microorganisms, disrupting their normal function and leading to cell death. It has been found to be effective against a wide range of organisms, including Gram-positive bacteria, Gram-negative bacteria, and fungi.

Antiangiogenic Activity[edit]

Squalamine inhibits the growth of new blood vessels, a process known as angiogenesis. This property has led to its investigation as a potential treatment for diseases characterized by excessive angiogenesis, such as cancer and age-related macular degeneration (AMD).

Clinical Use[edit]

Squalamine has been investigated in clinical trials for the treatment of cancer and age-related macular degeneration (AMD). While results have been promising, further research is needed to fully understand its potential therapeutic applications.